As many of you know from our communications late last year, MVMD has crossed an exciting milestone as we transition from an R&D-focused biotech start-up business into a commercially focused biotech entity.
The team has been working hard on our three core lines of business, which include novel innovations that improve the administration and efficacy of nutraceutical health and wellness products, an agricultural plant signaling technology that organically drives increases in crop yields and supports the reduction of fertilizer usage, and the application of solubilized drugs to positively impact the health of husbandry animals and aquatic species.
Our 2024 fiscal year starts on April 1st and I am personally very excited about the positive advancements our business will make this year as we continue to realize our mission of More Life and positive outcomes that impact human, plant and animal health.
